Impact of Tyrosine Kinase Inhibitors (TKIs) Combined With Radiation Therapy for the Management of Brain Metastases From Renal Cell Carcinoma

Background: Targeted therapy has transformed the outcome for patients with metastatic renal cell carcinoma. Their efficacy and safety have also been demonstrated in brain metastatic RCC. Preclinical evidence suggests synergism of radiation and tyrosine kinase inhibitors. Consequently, several studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Muhammad, Zhao, Zhihong, Arooj, Sumbal, Liao, Guixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390930/
https://www.ncbi.nlm.nih.gov/pubmed/32793497
http://dx.doi.org/10.3389/fonc.2020.01246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390930/
https://www.ncbi.nlm.nih.gov/pubmed/32793497
http://dx.doi.org/10.3389/fonc.2020.01246

Ejemplares similares